Gilles Subra leads his researches at the Institute of Biomolecules Max Mousseron (IBMM) in the field of peptide science. His main research topics are at the interface of chemistry and biology and notably the development of chemical tools and systems to explore biology. He develops methodologies for peptides synthesis, solid phase and combinatorial chemistry, and design of probes to enhance detection and quantification by mass spectrometry in biological media. More recently, he has been interested in the design of peptide-based materials and polymers. Some applications concern multi-ligand nanoparticles for cancer targeting, hydrogels for triggerable controlled release of drugs, functionalization of medical devices and dressings. His most recent research is related to the design of biomimetic peptide-based hydrogel used for 3D biofabrication and cell-based therapies and the design of hybrid nanostructure triggered by self-assembly and sol-gel process. Gilles Subra founded the solid phase and automated synthesis platform (SynBio3) of the IBMM whose mission is to develop solid supported reagents, linkers and methodologies for the synthesis of biomolecules.